Taevas
SwitzerlandPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in Switzerland
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences empowers your product's journey from regulatory approval to commercial success across diverse international markets, ensuring
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies
Timeline
8-12 weeks (initial strategy)
Deliverables
Strategy Report, Roadmap, Value Dossier
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Landscape Analysis
We provide comprehensive insights into the evolving regulatory frameworks, HTA requirements, and market dynamics across key global regions. This foundational analysis informs a tailored market access strategy that accounts for regional specificities.
In-depth analysis of target markets
Identification of regulatory hurdles and opportunities
How It Works
How It Works: Our Global Market Access Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Initial Assessment & Scope Definition
We begin with a comprehensive review of your product, target markets, and existing regulatory status. This phase defines the project scope, objectives, and identifies critical market access challenges and opportunities.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Regulatory Convergence & Divergence
While efforts towards global regulatory harmonization exist, significant regional differences persist in evidence requirements and HTA processes. Navigating this landscape requires deep local expertise combined with a global perspective.
Value-Based Access Demands
Payers globally are increasingly focused on real-world evidence and demonstrable value for money, shifting away from purely clinical efficacy. Products must prove their economic and patient impact to secure favorable access.
Complexity of Emerging Markets
Emerging markets offer significant growth potential but present unique challenges in terms of fragmented regulatory systems, evolving reimbursement models, and diverse stakeholder priorities, demanding highly adaptable strategies.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining the optimal pathway for market entry, pricing, and reimbursement across your target regions.
Payer Landscape & Reimbursement Dossier
Detailed analysis of payer requirements and a tailored dossier to support reimbursement applications in key markets.
Regulatory Pathway & Registration Roadmap
A clear, actionable plan detailing the specific regulatory steps, timelines, and requirements for product registration globally.
Value Proposition & Messaging Framework
A robust framework for communicating your product's unique value to diverse stakeholders, including payers, regulators, and clinicians.
Who This Is For
Use Cases
New Drug Launch
Accelerating a Novel Oncology Drug Launch Across EU5 & US
A biotech client with a breakthrough oncology drug needed to secure rapid market access in major Western markets post-FDA/EMA approval. Taevas developed a synchronized market access and HTA strategy, addressing specific regional payer demands and evidence requirements.
Outcome
Achieved optimal pricing and reimbursement in all target markets within 18 months of regulatory approval.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Unlock the full potential of your life sciences product across international borders. Partner with Taevas Life Sciences to navigate the complexities of global market access with confidence.
Expert Global Insights
Tailored Strategic Solutions
Accelerated Market Entry
Maximized Commercial Value